Document Detail


Possible long-term teratogenic effect of isotretinoin in pregnancy.
MedLine Citation:
PMID:  19961047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The isotretinoin, a 13-cis-retinoic acid, has revolutionized the management of severe treatment-resistant acne and it has been widely used for a range of dermatological conditions, in 90% of the time in young women between 13 and 45 years of age. This agent has severe teratogenic effects, as serious craniofacial, cardiovascular, thymic and central nervous system malformations. The baseline population risk of malformations is 3-5%, but it increases to almost 30% in women exposed to isotretinoin during the first trimester of pregnancy. Generally, patients in treatment with isotretinoin avoid eventual pregnancy during assumption and, after its stopping, fertility and foetal development are normal once circulating isotretinoin levels return to normal. There are no known deleterious effects on male fertility and on long-term teratogenic effect of isotretinoin. In this report, we suppose the possibility to develop a foetal malformations after a long-term wash out from isotretinoin therapy. A 32 year-old healthy nullipara pregnant woman, with an uneventful past gynaecological history, was admitted in Hospital, with a severe depressive syndrome in a 18 weeks malformed pregnancy for thoraco-omphalopagus conjoined twins. She only assumed isotretinoin, at dose of 1 mg/kg a day, for a severe and scarring acne for 7 months. After 3 months of pharmacological wash out, patient become pregnant and manifested this severe malformation. Woman interrupted gestation, by labour induction.
Authors:
A Malvasi; A Tinelli; A Buia; G F De Luca
Related Documents :
8829257 - Pregnancy outcome after treatment with the ergot derivative, cabergoline.
2621027 - Nitrosatable drug exposure during pregnancy and adverse pregnancy outcome.
20841587 - Safety of using montelukast during pregnancy.
7829427 - Epilepsy and pregnancy: mother and child.
6816827 - Placental location in pregnancies following cesarean section.
1430097 - Regulation of immunoreactive inhibin patterns in baboon pregnancy: maternal, placental,...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  13     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:    2009 Sep-Oct
Date Detail:
Created Date:  2009-12-07     Completed Date:  2010-01-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  393-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Santa Maria Hospital, Bari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology*
Acne Vulgaris / drug therapy
Adult
Dermatologic Agents / adverse effects*,  therapeutic use
Female
Humans
Isotretinoin / adverse effects*,  therapeutic use
Pregnancy
Pregnancy Complications / chemically induced
Teratogens / toxicity
Time Factors
Twins, Conjoined / pathology
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Teratogens; 4759-48-2/Isotretinoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A neglected giant subcutaneous leiomyosarcoma of the shoulder: a case report.
Next Document:  The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis pa...